tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Stock Investors

76 Followers
Based on 722,977 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold INKT
On average, investors allocate 0.00% of their portfolios to INKT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 722,977 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding INKT

2.3%
Last 7
Days
2.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding INKT, out of 722,977 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

INKT Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
<0.01%
$0.92
Based on the activity of 13,596 investors who made their portfolios public
The table shows changes in INKT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

INKT Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.94%
-1.55%
-3.54%
723.19M
Consumer Cyclical
Coherus Biosciences
2.68%
-0.92%
-3.42%
253.91M
Healthcare
Assertio Therapeutics
2.70%
-1.25%
-4.65%
98.80M
Healthcare
DraftKings
7.22%
-0.16%
+1.13%
41.01B
Consumer Cyclical
Devon Energy
5.45%
-0.98%
-2.69%
31.15B
Energy
UiPath
3.52%
-0.89%
+3.57%
13.06B
Technology
Marvell
4.73%
+1.96%
+10.89%
57.26B
Technology
Merck & Company
4.06%
+0.21%
+0.71%
317.37B
Healthcare
Micron
5.70%
+11.23%
+26.64%
129.71B
Technology
Marathon Digital Holdings
5.68%
-0.85%
+6.82%
5.92B
Financial
Based on the activity of 722,977 active portfolios
Open your Smart Portfolio

INKT Investor Analysis

INKT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.3%
of INKT holders
are under 35
Average Segment Performance
Average P/E Ratio56.24
Beta7.70
Dividend Yield5.72%
INKT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
28.6%
of INKT holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.68
Beta11.71
Dividend Yield6.34%
INKT investors over 55

Over 55

3.9%
Last 30 days
Holdings Change
57.1%
of INKT holders
are over 55
Average Segment Performance
Average P/E Ratio53.31
Beta6.02
Dividend Yield6.03%
Overview of age group and performance of INKT stock investors
See who invests in INKT according to age group and performance.

FAQ

How many retail Investors hold INKT?
<0.1% of TipRanks' retail investors hold INKT in their portfolios.
    What is INKT Investor Sentiment?
    INKT’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of INKT in the last 7 days?
      ▲ 2.3% of TipRanks' retail investors changed their holding of INKT in the last 7 days.
        What percentage of retail investors changed their holding of INKT in the last 30 days?
        ▲ 2.4% of TipRanks' retail investors changed their holding of INKT in the last 30 days.
          What is the average age of retail investors who hold INKT?
          The average age of INKT Holders is over 55.
            What other stocks have INKT investors also bought?
            INKT Investors also bought CHPT, CHRS, ASRT, DKNG, DVN, PATH, MRVL, MRK, MU, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis